67.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Will Soleno Therapeutics Inc. (6XC) stock justify high valuationMarket Performance Report & Long-Term Capital Growth Strategies - newser.com
How to escape a deep drawdown in Soleno Therapeutics Inc.Weekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Insider Monkey
What Wall Street predicts for Soleno Therapeutics Inc. stock priceRecession Risk & AI Forecast Swing Trade Picks - newser.com
Can Soleno Therapeutics Inc. stock deliver sustainable ROEEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Detecting support and resistance levels for Soleno Therapeutics Inc.2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
How Soleno Therapeutics Inc. (6XC) stock stacks up against competitors2025 Market Outlook & Smart Money Movement Tracker - newser.com
Is Soleno Therapeutics Inc. stock supported by strong cash flows2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
How Soleno Therapeutics Inc. stock performs in rate cut cycles2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Momentum divergence signals in Soleno Therapeutics Inc. chartMarket Activity Recap & Safe Entry Trade Reports - newser.com
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - WV News
Soleno Therapeutics Insiders Sold US$23m Of Shares Suggesting Hesitancy - 富途牛牛
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
What analysts say about Soleno Therapeutics Inc stockTrading Volume Surges & Explore Stocks for Free with Our Research Portal - Early Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure - Investing.com Canada
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure By Investing.com - Investing.com South Africa
SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire Inc.
Wells Fargo Sticks to Their Buy Rating for Soleno Therapeutics (SLNO) - The Globe and Mail
Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):